drug discovery ai

Astellas Pharma has deployed NVIDIA’s Boltz-2 NIM to guide membrane-protein drug discovery, using Tokyo-1 as a computational foundation and reporting that 10 selected compounds all showed the expected medicinal effects while evaluated compounds fell by more than 90% and the research period by...